With the delay in ICD-10, many insurers now have to slow down a mammoth IT project and, potentially more disruptive, make adjustments to a whole slew of programs and contracts.
With the delay in ICD-10, many insurers now have to slow down a mammoth IT project and, potentially more disruptive, make adjustments to a whole slew of programs and contracts.
While most payers’ ICD-10 conversions are generally ahead of organizations in other healthcare sectors, this “very late breaking change in the deadline is like throwing a great big wrench into a very complicated process that’s well underway,” as Jordan Battani, CSC’s managing director for emerging health practices, put it.
On an industry-wide level, as America’s Health Insurance Plans sees it, the delay is bound to “cause undue confusion and administrative challenges,” leaving payers and providers in “a stalled transition between two different coding systems.”
Read the full story here: http://bit.ly/1k0Rby7
Source: Healthcare Payer News
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More